is ghk cu approved by fda ghk-cu injection I hear it all the time — “GHK-Cu isn't An FDA panel on Friday

A strongly worded consumer advisory from one clinic flatly states: The prescription of this is malpractice and you could be owed for damages.

BPC-157 has a molecular weight of approximately 1,419 Da on the larger end for nasal mucosal absorption which may constrain bioavailability compared to smaller peptides like Semax (which weighs 604 Da and is specifically designed for nasal delivery).8 Who nasal delivery may be relevant for (research context): Neurological or brain-adjacent applications Patients for whom injection is contraindicated Situations requiring rapid onset with non-invasive administration Research protocols studying nose-to-brain peptide pathways What to be realistic about: No peer-reviewed human trials on intranasal BPC-157 exist as of 2026 Nasal absorption of BPC-157 is less predictable than for smaller peptides Dosing standardisation for nasal BPC-157 is not established Consult a licensed provider before considering this route Peptide Delivery Method Comparison Table How to Choose the Right BPC-157 Delivery Method for Your Goal Matching the delivery method to the clinical goal is the single most important decision in BPC-157 therapy

Together, they may promote better wound healing.7 25 Where to get BPC-157 Unfortunately, with the growing popularity of BPC-157 comes a growing market of not-so-trustworthy sellers looking to cash in on the craze

It stimulated the production of extracellular matrix (ECM) proteins and reduced the production of pro-inflammatory cytokines [25]